Stay updated on High Dose Cytarabine + Pembrolizumab in AML Clinical Trial

Sign up to get notified when there's something new on the High Dose Cytarabine + Pembrolizumab in AML Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the High Dose Cytarabine + Pembrolizumab in AML Clinical Trial page

  1. Check
    today
    Change Detected
    Summary
    The page now displays revision v3.7.0, replacing the previous v3.6.6. This indicates the study page has been updated to a newer version.
    Difference
    0.1%
    Check dated 2026-09-16T00:16:10.000Z thumbnail image
  2. Check
    8 days ago
    No Change Detected
  3. Check
    15 days ago
    Change Detected
    Summary
    Revision updated from v3.6.5 to v3.6.6, indicating a small backend/template update for the study page. This update does not alter the study details, eligibility criteria, or locations; it seems to be a platform version bump.
    Difference
    0.1%
    Check dated 2026-09-01T19:43:10.000Z thumbnail image
  4. Check
    22 days ago
    No Change Detected
  5. Check
    36 days ago
    Change Detected
    Summary
    This change updates the page's underlying version from v3.6.4 to v3.6.5, indicating a small maintenance update to the template or platform without modifying the study details.
    Difference
    0.1%
    Check dated 2026-08-11T17:59:09.000Z thumbnail image
  6. Check
    50 days ago
    Change Detected
    Summary
    The page shows a revision tag updated from v3.6.3 to v3.6.4, indicating a minor software update to the underlying system. This is a technical version bump and does not change the clinical trial details or visible content.
    Difference
    0.1%
    Check dated 2026-07-28T10:53:08.000Z thumbnail image
  7. Check
    78 days ago
    Change Detected
    Summary
    The revision label was updated from v3.6.0 to v3.6.3, indicating a minor update to the document history. The change reflects a version bump rather than a substantive modification to the study details.
    Difference
    0.1%
    Check dated 2026-06-30T00:42:13.000Z thumbnail image
  8. Check
    93 days ago
    Change Detected
    Summary
    The page now shows a recruitment status, and adds guidance sections for reading the study record and joining the study. The Interventions/Treatment label is reformatted and the revision tag updated from v3.5.5 to v3.6.0.
    Difference
    0.5%
    Check dated 2026-06-15T18:57:16.000Z thumbnail image

Stay in the know with updates to High Dose Cytarabine + Pembrolizumab in AML Clinical Trial

Enter your email address, and we'll notify you when there's something new on the High Dose Cytarabine + Pembrolizumab in AML Clinical Trial page.